Alfuzosin HCL ER 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FQ2S9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,419
Award facts
- Contract value 100% obligated
- $10,418.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets (90-count) with a ceiling value of $10,418.52. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded and non-set-aside, demonstrating the company's capability to meet federal procurement requirements through open competition across diverse therapeutic domains and order values.
Quick answers
Who was awarded contract SPE2DB25FQ2S9?
SPE2DB25FQ2S9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FQ2S9 worth?
The government has obligated $10,419 on SPE2DB25FQ2S9.
Is contract SPE2DB25FQ2S9 an order under another contract?
Yes. SPE2DB25FQ2S9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ2S9 competed?
The extent of competition for SPE2DB25FQ2S9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award